Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Intellia Therapeutics Earnings Perspective: Return On Capital Employed
February 28, 2023
Tickers
NTLA
Tags
Benzinga
Earnings
BZI/ROCE
From
Benzinga
Earnings Scheduled For February 23, 2023
February 23, 2023
Tickers
LAW
LAZY
LKQ
LMAT
Tags
TA
RHP
BZI/UE
From
Benzinga
Better Buy: Beam Therapeutics or Intellia Therapeutics?
February 22, 2023
Tickers
ARKK
BEAM
CRSP
NTLA
Tags
PFE
CRSP
NTLA
From
Motley Fool
3 Deeply Undervalued Stocks That Could Double Your Money
February 15, 2023
Tickers
NTLA
PDSB
VERV
Tags
Market News
Recent Press Releases
VERV
From
Motley Fool
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
February 07, 2023
Tickers
ARKG
ARKK
CMPS
DNA
Tags
DNA
CMPS
ARKG
From
Motley Fool
3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129%
February 06, 2023
Tickers
ARKK
BEAM
CRSP
NTLA
Tags
NTLA
CRSP
Recent Press Releases
From
Motley Fool
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
February 01, 2023
Tickers
CRSP
EDIT
NTLA
Tags
Briefs
Price Target
Health Care
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Tickers
AEP
AMD
APPS
AQUA
Tags
TSHA
VNRX
MCO
From
Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
Tickers
BEAM
BIIB
CLLS
CRSP
Tags
Stocks to Buy
REGN
BIIB
From
InvestorPlace
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
January 25, 2023
Tickers
ABBV
CRBU
CRSP
NTLA
Tags
ABBV
Market News
VRTX
From
InvestorPlace
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
Tickers
CRSP
GNOM
MYGN
NTLA
Tags
GNOM
Market News
NASDAQ:CRSP,NASDAQ:GNOM,NASDAQ:NTLA,NASDAQ:MYGN,NASDAQ:SRPT
From
InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
January 24, 2023
Tickers
NTLA
TDOC
TSLA
Tags
TSLA
NTLA
TDOC
From
Motley Fool
Expert Ratings for Intellia Therapeutics
January 24, 2023
Tickers
NTLA
Tags
BZI/AAR
Benzinga
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
January 24, 2023
Tickers
AEP
AIRC
AKAM
AKTS
Tags
CRWD
CSTR
WFG
From
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 20, 2023
Tickers
ARQQ
BAX
BKD
CRON
Tags
FAZE
GRNT
SKWD
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
January 19, 2023
Tickers
AGI
ALPN
BKR
CDE
Tags
CDE
NOV
TPH
From
Benzinga
2 Risky Cathie Wood Stocks to Buy Today And Hold For 5 Years
January 07, 2023
Tickers
ARKK
CRSP
NTLA
VRTX
Tags
VRTX
NTLA
Recent Press Releases
From
Motley Fool
The Latest Analyst Ratings for Intellia Therapeutics
January 04, 2023
Tickers
NTLA
Tags
Market News
NTLA
Analyst Ratings
From
Benzinga
1 Cathie Wood Stock to Buy While It's Affordable, and 1 to Avoid (for Now)
December 30, 2022
Tickers
ARKK
BLUE
CRSP
NTLA
Tags
VRTX
Recent Press Releases
BLUE
From
Motley Fool
7 ‘Next Big Things’ for Investors to Buy for 2023
December 13, 2022
Tickers
ANET
AVGO
BEAM
DQ
Tags
BEAM
MATX
Market News
From
InvestorPlace
Ulta Beauty To Rally Around 22%? Here Are 10 Other Price Target Changes For Friday
December 02, 2022
Tickers
ASAN
AVB
CAKE
CRM
Tags
Pre/Market Outlook
Market News
Analyst Ratings
From
Benzinga
Analyst Ratings for Intellia Therapeutics
December 02, 2022
Tickers
NTLA
Tags
Benzinga
BZI/AAR
Market News
From
Benzinga
NTLA Stock Falls as Intellia Therapeutics Announces Public Offering
December 01, 2022
Tickers
FIVE
NTLA
SPLK
Tags
SPLK
Market News
NTLA
From
InvestorPlace
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
November 15, 2022
Tickers
CMBM
GMDA
JOBY
MOTS
Tags
GMDA
Markets
Price Target
From
Benzinga
Intellia's Hereditary Angioedema Candidate Shows Reduction In Associated Biomarkers, Attack Rates
November 14, 2022
Tickers
NTLA
Tags
Market News
Health Care
Benzinga
From
Benzinga
Recap: Intellia Therapeutics Q3 Earnings
November 03, 2022
Tickers
NTLA
Tags
Benzinga
Earnings
NTLA
From
Benzinga
Earnings Preview For Intellia Therapeutics
November 02, 2022
Tickers
NTLA
Tags
Benzinga
Earnings
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Tickers
ABMD
ACAD
AKTX
AMC
Tags
SHOO
INO
RPT
From
Benzinga
3 Cathie Wood Stocks to Buy and Hold for 10 Years
October 19, 2022
Tickers
ARKK
CRSP
NTLA
TDOC
Tags
Recent Press Releases
Market News
ARKK
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Tickers
ABC
ACMR
ADI
AMGN
Tags
CCCC
CW
SPCE
From
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today